One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ-PKAc fusion oncoprotein. However, the underlying mechanism of DNAJ-PKAc’s ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...